14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 24 Apr 2024

Trading levels for CASI

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.61 7.41 %
R2 2.53 4.11 %
R1 2.48 2.07 %
Current price: 2.43
Support S1 2.32 -4.54 %
S2 2.27 -6.58 %
S3 2.19 -9.88 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.00 23.46 %
R2 2.96 21.81 %
R1 2.65 9.05 %
Current price 2.43
Support S1 2.34 -3.70%
S2 2.25 -7.41%
S3 2.24 -7.82%

CASI Predictions History

1 year ago
Pavel Kupershtoh predicted that CASI for 2022-08-01 is going

Rank:

3 years ago
JS predicted that CASI for 2020-12-22 is going $2.83 (-7.82%)

3 years ago
JS predicted that CASI for 2020-12-21 is going $2.75 (-5.50%)

4 years ago
NameNotImportant predicted that CASI for 2019-05-02 is going $3.15 (-3.37%)

6 years ago
JS predicted that CASI for 2018-01-23 is going $4.10 (-1.20%)

6 years ago
Jacob.Astorian.16808 predicted that CASI for 2018-01-19 is going $7.00 (75.88%)

Rank:

6 years ago
Balagurubaran predicted that CASI for 2017-12-13 is going $2.70 (0.75%)

Rank:
Click to get the best stock tips daily for free!

About CASI Pharmaceuticals

CASI Pharmaceuticals CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's product pipeline includes CNCT19, an autologous CD19 CAR-T inve... CASI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT